You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dose titration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension, Cardiovascular Diseases Trial (Curate.AI, Telemonitoring)

Not yet recruiting
  • Hypertension
  • Cardiovascular Diseases
  • Curate.AI
  • Telemonitoring
  • (no location specified)
Jul 19, 2022

Gastric Cancer Trial in Shanghai (Apatinib)

Completed
  • Gastric Cancer
  • Shanghai, Shanghai, China
    Shanghai 6th People's Hospital
Feb 24, 2022

Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

Recruiting
  • Iron Deficiency Anemia
  • Adelaide, South Australia, Australia
  • +8 more
Jun 23, 2023

Healthy Trial (N,N-Dimethyltryptamine (54 mg), N,N-Dimethyltryptamine (108 mg), N,N-Dimethyltryptamine (162 mg))

Recruiting
  • Healthy
  • N,N-Dimethyltryptamine (54 mg)
  • +5 more
  • Basel, Switzerland
    Universtity Hospital Basel
Jan 30, 2023

Overweight, Obesity Trial (LY3502970, Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • (no location specified)
Aug 29, 2023

Secondary Hyperparathyroidism Trial (SHR6508, Cinacalcet)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • (no location specified)
Dec 21, 2022

Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy

Active, not recruiting
  • Diabetes Mellitus Type 2 - Insulin-Treated
  • Smartphone application and web portal
  • Standard Insulin Therapy Education
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jan 6, 2023

Overweight, Obesity Trial in San Antonio, Salt Lake City (LY3305677, Placebo)

Recruiting
  • Overweight
  • Obesity
  • San Antonio, Texas
  • +1 more
Jan 3, 2023

Attention Deficit Disorder With Hyperactivity Trial in Las Vegas, Durham (Aptensio XR, Placebo)

Completed
  • Attention Deficit Disorder With Hyperactivity
  • Aptensio XR
  • Placebo
  • Las Vegas, Nevada
  • +1 more
Nov 10, 2021

Spastic Cerebral Palsy Trial (IncobotulinumtoxinA 100 UNT [Xeomin])

Not yet recruiting
  • Spastic Cerebral Palsy
  • IncobotulinumtoxinA 100 UNT [Xeomin]
  • (no location specified)
Apr 14, 2022

Hypercholesterolemia Trial (pitavastatin, atorvastatin)

Completed
  • Hypercholesterolemia
  • (no location specified)
Apr 4, 2022

Trichotillomania (Hair-Pulling Disorder) Trial in New Haven (Valbenazine Oral Capsule, Placebo Oral capsule)

Not yet recruiting
  • Trichotillomania (Hair-Pulling Disorder)
  • Valbenazine Oral Capsule
  • Placebo Oral capsule
  • New Haven, Connecticut
    Yale Child Study Center
Jul 21, 2022

Obesity Trial in Korea, Republic of (Qsymia 3.75Mg-23Mg Extended Release Capsule, Qsymia 7.5Mg-46Mg Extended Release Capsule,

Recruiting
  • Obesity
  • Qsymia 3.75Mg-23Mg Extended Release Capsule
  • +4 more
  • Seoul, Dongdaemun-gu, Korea, Republic of
  • +7 more
May 12, 2022

Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)

Terminated
Has Results
  • Microvascular Coronary Artery Disease
  • Los Angeles, California
  • +9 more
Mar 15, 2022

NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV Trial in Worldwide (Dacomitinib)

Active, not recruiting
  • NSCLC Stage IIIB
  • +4 more
  • Hong Kong, Hong Kong
  • +8 more
Jan 10, 2023

Vitamin D Deficiency, End Stage Renal Disease Trial (ergocalciferol supplementation, dialysis techniques, sunlight exposure

Not yet recruiting
  • Vitamin D Deficiency
  • End Stage Renal Disease
  • ergocalciferol supplementation
  • +2 more
  • (no location specified)
Jun 26, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • Palo Alto, California
  • +11 more
Jan 16, 2023

Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

Recruiting
  • Progressive Multiple Sclerosis
  • Placebo
  • Masitinib (4.5)
  • Lille, France
  • +1 more
Jul 1, 2022

Gout Trial in Taipei (Stepwise dose titration of febuxostat and low-dose colchicine, Fixed dose febuxostat and low-dose

Recruiting
  • Gout
  • Stepwise dose titration of febuxostat and low-dose colchicine
  • Fixed dose febuxostat and low-dose colchicine
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 24, 2021

Duchenne Muscular Dystrophy Trial in Los Angeles, Chicago, Baltimore (SRP-4045, Placebo)

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • Los Angeles, California
  • +2 more
Apr 23, 2021

Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo Trial (Ritlecitinib, Placebo)

Not yet recruiting
  • Stable Nonsegmental Vitiligo
  • Active Nonsegmental Vitiligo
  • (no location specified)
Oct 2, 2023

Healthy Volunteer Trial in Shinjuku-ku (TAK-935, Placebo)

Completed
Has Results
  • Healthy Volunteer
  • Shinjuku-ku, Tokyo, Japan
    Clinical Research Hospital Tokyo
Nov 10, 2021

Healthy Trial (BI 456906, Microgynon®)

Not yet recruiting
  • Healthy
  • (no location specified)
Jun 14, 2023

Hypertension, Portal, Liver Cirrhosis Trial (Placebo, BI 685509)

Not yet recruiting
  • Hypertension, Portal
  • Liver Cirrhosis
  • Placebo
  • BI 685509
  • (no location specified)
Oct 9, 2023

Hypertension, Pulmonary Trial in Worldwide (Riociguat (Adempas, BAY63-2521))

Active, not recruiting
Has Results
  • Hypertension, Pulmonary
  • Riociguat (Adempas, BAY63-2521)
  • Cali, Valle Del Cauca, Colombia
  • +15 more
Jan 18, 2023